Zdrowie i gospodarka · 03/11/1997

FDA Issues Guidance on Reporting of Errors and Accidents in Biological Product Manufacturing

The U.S. Food and Drug Administration (FDA) has issued a guidance document requiring pharmaceutical companies to report errors and accidents in the manufacturing of biological products, such as vaccines and insulin, within a specified timeframe. The new policy aims to enhance transparency and safety in the production process.